Navigation Links
Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection
Date:4/22/2013

ackage inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward Looking Statements
Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements in this press release include statements regarding potential therapeutic indication and use, safety, efficacy, tolerability and potential of VP20621, statements that VP20621 may prevent infection by toxin-producing strains of C. difficile and how colonization rates may be increased further. Our actual results could differ materially from those results expressed in, or implied by, these forward-looking statements. The development and commercialization of pharmaceutical products is subject to risks and uncertainties. The safety, colonization and efficacy data described in this press release are preliminary and additional review of the data may reveal additional findings which may not be consistent with this press release. The studies described in this press release represent the results of a Phase 2 study with VP20621 and the results of the study may not be predictive of how VP20621 will perform in future studies. There can be no assurance that that The FDA or EMA may view the data regarding VP20621 as insufficient or inconclusive, request additional data, require additional clinical studies, del
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... lot of discussion in the medical community revolves around figuring ... conditions. As medical science advances, doctors and surgeons often feel ... consider to be more cutting edge. Yet, when it comes ... treatment that stands out as the best solution in all ...
(Date:1/23/2015)... 2015  MedScope ( www.medscope.org ), the leading provider of ... Connected World magazine Connected World Award for ... can be used anywhere, anytime. The nomination was made ... In nominating MedScope, Landon Garner , Director of ...
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader ... and partnership with RCA Medical, a subsidiary of Ascendis ... . Each year, hundreds of millions of ... infections as organisms are transmitted from patient to patient ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... liquid form has contributed to some dosage errors due to ... the Tamiflu pill form when developing their own liquid version ... Two pediatric patients in Pennsylvania hospitals received overdoses ... of unawareness among staff as to the concentration of the ...
... COPENHAGEN, November 2 Nuevolution ... derived from its collaboration with,Merck & Co. Inc., Whitehouse ... was triggered following identification of several candidate,molecules that conformed ... original agreement. These include several accepted drug-like,characteristics and nanomolar ...
Cached Medicine Technology:Alert: Two Overdoses of Tamiflu in Pediatric Patients in Pennsylvania 2Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc. 2
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
(Date:1/22/2015)... has released a new blog post explaining the importance of keeping ... costs of an auto insurance policy . , Clients who ... for their vehicle insurance policies. The safety a vehicle offers from ... Because of this, drivers should always carry a first aid kit ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... April 29 The very real possibility of a swine ... organizations that have not developed a plan to cope with ... Law & Business. To reduce the impact on operations, ... all organizations that haven,t done so to begin continuity planning ...
... after daily, Friday prayersWASHINGTON, April 29 A prominent ... on Islamic religious leaders, or imams, to use daily ... a platform for providing information about preventing the spread ... said imams are in a unique position to offer ...
... Onsite Pathogen DetectionST. GEORGE, Utah, April 29 DxNA announced ... flu and related world threat, it is developing a diagnostic ... H1N1 virus (known as swine flu) anywhere it is needed ... less than 10 pounds. The Company anticipates having a ...
... Sign Legislation to Provide Access to Medigap Secondary Insurance ... Fla., April 29 Following unanimous support in the ... voted unanimously for the bill renamed "The Alonzo Mourning ... population of Florida,s kidney failure patients and the disabled ...
... the nation,s leader in pain prescription monitoring, announced ... with Aetna to offer Aetna,s network of providers ... monitoring process. Ameritox,s patented Rx Guardian(SM) methodology is ... a patented methodology to help physicians assess whether ...
... of Care Support of AmericaNEW YORK, April 29 "Thirty ... their widowed or single Moms -- often from far away ... of Care Support of America ... dynamics. " This can be extraordinarily stressful for all ...
Cached Medicine News:Health News:If You Haven't Yet, Plan Now for a Pandemic, CCH Advises Employers 2Health News:If You Haven't Yet, Plan Now for a Pandemic, CCH Advises Employers 3Health News:If You Haven't Yet, Plan Now for a Pandemic, CCH Advises Employers 4Health News:CAIR Asks U.S. Muslim Prayer Leaders to Urge Swine Flu Precautions 2Health News:CAIR Asks U.S. Muslim Prayer Leaders to Urge Swine Flu Precautions 3Health News:DxNA to Use its Rapid Detection Platform to Simplify Testing for Swine Flu (H1N1 Virus) 2Health News:DxNA to Use its Rapid Detection Platform to Simplify Testing for Swine Flu (H1N1 Virus) 3Health News:Florida Legislature Unanimously Supports 'The Alonzo Mourning Access to Care Act' to Help State's Kidney Failure Patients and the Disabled 2Health News:Florida Legislature Unanimously Supports 'The Alonzo Mourning Access to Care Act' to Help State's Kidney Failure Patients and the Disabled 3Health News:Ameritox(R) Contracts With Aetna for Prescription Drug Monitoring Services 2Health News:10 Ways to Care for Mom on Mother's Day 2Health News:10 Ways to Care for Mom on Mother's Day 3Health News:10 Ways to Care for Mom on Mother's Day 4
Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
... Oxygen Conservation Device. Bypass 6200: ... ,6200 Accessories: , OCD870C CGA ... 540 Regulator , OCD2001-18 Carrying ... , CP2140 Vertical M-6 Cylinder ...
... Medical announces its new CVD Diamond Knives. ... incredible sharpness of diamonds to be used ... blade sharpness improves stromal reapproximation, enhances healing, ... knives offer unlimited uses, and are available ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
Medicine Products: